Etoricoxib Tablets
developed to address chronic pain indicated to relieve arthritic inflammation.
Strengths: 60 · 90 · 120mg
Where to Check Availability
Medicine details
- Alternative names
Arcoxia
- Therapeutic class
Cyclo-oxygenase-2 Inhibitor
- Pharmacological class
NSAID
- Minor side effects
nausea; dizziness; peripheral oedema
- Moderate side effects
flatulence; transaminase elevation; hypertension
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Patient summary
developed to address chronic pain indicated to relieve arthritic inflammation.
- Prescription status
POM
- Manufacturer
MSD
- Onset Time
24 minutes
- Duration
24 hours
- Storage instructions
Store below 30°C.
- Drug interactions
warfarin; lithium; methotrexate
- Age restrictions
Do not treat children under 16.
- Pregnancy and breastfeeding
Do not use during pregnancy.
Contraindications
active peptic ulceration; severe hepatic dysfunction; inflammatory bowel disease; congestive heart failure
Precautions and warnings
monitor blood pressure regularly; use lowest effective dose for shortest duration
Serious side effects
gastrointestinal haemorrhage — requires immediate medical attention; myocardial infarction — requires immediate medical attention
Mechanism of action
Etoricoxib is a selective COX-2 inhibitor that suppresses prostaglandin synthesis by blocking the cyclo-oxygenase-2 enzyme pathway without significantly impacting COX-1 at therapeutic doses, thereby reducing inflammation and pain.
Etoricoxib Tablets
developed to address chronic pain indicated to relieve arthritic inflammation.
Editorial Notes
- Active ingredient(s): Etoricoxib
- Listed indication(s): Osteoarthritis, Rheumatoid Arthritis, Ankylosing Spondylitis, Gouty Arthritis
Usually available as
- 180 tablets - 60 mg1380-60-mg-16561
- 90 tablets - 90 mg1380-90-mg-16571
- 60 tablets - 120 mg1380-120-mg-16564